organic acidemia

{{Empty section|date=November 2024}}

Most of the organic acidemias result from defective autosomal genes for various enzymes important to amino acid metabolism. Neurological and physiological harm is caused by this impaired ability to synthesize a key enzyme required to break down a specific amino acid, or group of amino acids, resulting in acidemia and toxicity to specific organ systems. Most are inherited as autosomal recessive diseases.{{Cite journal |last1=Häberle |first1=Johannes |last2=Boddaert |first2=Nathalie |last3=Burlina |first3=Alberto |last4=Chakrapani |first4=Anupam |last5=Dixon |first5=Marjorie |last6=Huemer |first6=Martina |last7=Karall |first7=Daniela |last8=Martinelli |first8=Diego |last9=Crespo |first9=Pablo S. |date=2012-05-29 |title=Suggested guidelines for the diagnosis and management of urea cycle disorders |journal=Orphanet Journal of Rare Diseases |volume=7 |issue=1 |pages=32 |doi=10.1186/1750-1172-7-32 |issn=1750-1172 |pmc=3488504 |pmid=22642880 |doi-access=free}}{{Cite journal |last1=Kölker |first1=Stefan |last2=Christensen |first2=Ernst |last3=Leonard |first3=James V. |last4=Greenberg |first4=Cheryl R. |last5=Boneh |first5=Avihu |last6=Burlina |first6=Alberto B. |last7=Burlina |first7=Alessandro P. |last8=Dixon |first8=Marjorie |last9=Duran |first9=Marinus |date=2011 |title=Diagnosis and management of glutaric aciduria type I – revised recommendations |journal=Journal of Inherited Metabolic Disease |volume=34 |issue=3 |pages=677–694 |doi=10.1007/s10545-011-9289-5 |issn=0141-8955 |pmc=3109243 |pmid=21431622}}

Organic acidemias are usually diagnosed in infancy, characterized by urinary excretion of abnormal amounts or types of organic acids. The diagnosis is usually made by detecting an abnormal pattern of organic acids in a urine sample by gas chromatography-mass spectrometry. In some conditions, the urine is always abnormal, in others, the characteristic substances are only present intermittently. Many of the organic acidemias are detectable by newborn screening with tandem mass spectrometry.{{Cite journal |vauthors=Dionisi-Vici C, Deodato F, Raschinger W, Rhead W, Wilcken B |year=2006 |title=Classical organic acidurias, propionic aciduria, methylmalonic aciduria, and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry |journal=J Inherit Metab Dis |volume=29 |issue=2–3 |pages=383–389 |doi=10.1007/s10545-006-0278-z |pmid=16763906 |s2cid=19710669 |doi-access=free}}

These disorders vary in their prognosis, from manageable to fatal, and usually affect more than one organ system, especially the central nervous system.{{cn|date=November 2024}}

Neurological damage and developmental delay are common factors in diagnosis, with associated symptoms ranging from poor feeding to slow growth, lethargy, vomiting,

dehydration, malnutrition, hypoglycemia, hypotonia, metabolic acidosis, ketoacidosis, hyperammonemia, and if left untreated, death.{{Cite book |last1=Pellock |first1=John M. |url=https://books.google.com/books?id=t0EfAwAAQBAJ&q=organic+acidemia+symptoms&pg=PA326 |title=Neurologic Emergencies in Infancy and Childhood |last2=Myer |first2=Edwin C. |date=2013-10-22 |publisher=Butterworth-Heinemann |isbn=9781483193922 |access-date=2015-04-17}}

Treatment or management of organic acidemias vary; e.g. see methylmalonic acidemia, propionic acidemia, isovaleric acidemia, and maple syrup urine disease.{{citation needed|date=July 2022}}

As of 1984 there were no effective treatments for all of the conditions, though treatment for some included a limited protein/high carbohydrate diet, intravenous fluids, amino acid substitution, vitamin supplementation, carnitine, induced anabolism,{{Cite book |title=Organic Acidurias |vauthors=Saudubray JM, Ogier H, Charpentier C, Depondt E, Couda FX, Munnich A, Mitchell G, Rey F, Rey J, Frazal J |journal=Journal of Inherited Metabolic Disease |year=1984 |isbn=978-94-010-8975-3 |volume=7 |pages=2–9 |chapter=Hudson Memorial Lecture Neonatal Management of Organic Acidurias. Clinical Update |doi=10.1007/978-94-009-5612-4_2 |pmid=6434839 |issue=Suppl. 1}} and in some cases, tube-feeding.

As of 1993 beta-ketothiolase deficiency and other OAs were managed by trying to restore biochemical and physiologic homeostasis; common therapies included restricting diet to avoid the precursor amino acids and use of compounds to either dispose of toxic metabolites or increase enzyme activity.{{Cite journal |last1=Seashore |first1=MR |last2=Pagon |first2=RA |last3=Adam |first3=MP |last4=Ardinger |first4=HH |last5=Bird |first5=TD |last6=Dolan |first6=CR |last7=Fong |first7=CT |last8=Smith |first8=RJH |last9=Stephens |first9=K |date=1993 |title=The Organic Acidemias: An Overview |publisher=Gene Reviews (R) Seattle (WA): University of Washington, Seattle; 1993-2015.}}

• {{section link|ACAT1|Ketothiolase deficiency}}, another type of OA

{{Reflist}}

{{Medical resources

| ICD10 =

| ICD9 =

| ICDO =

| OMIM =

| DiseasesDB =

| MedlinePlus =

| eMedicineSubj =

| eMedicineTopic =

| MeSH =

| GeneReviewsNBK =

| GeneReviewsName =

| Orphanet = 289899

}}

• [https://web.archive.org/web/20100527193307/http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=oa-overview GeneReviews/UW/NIH entry on Organic acidemias]

{{Amino acid metabolic pathology}}

{{DEFAULTSORT:Organic Acidemia}}

Category:Amino acid metabolism disorders

Category:Rare diseases